Literature DB >> 12363217

3D-QSAR and molecular modeling of HIV-1 integrase inhibitors.

Mahindra T Makhija1, Vithal M Kulkarni.   

Abstract

Three-dimensional quantitative structure-activity relationship (3D QSAR) methods were applied on a series of inhibitors of HIV-1 integrase with respect to their inhibition of 3'-processing and 3'-end joining steps in vitro. The training set consisted of 27 compounds belonging to the class of thiazolothiazepines. The predictive ability of each model was evaluated using test set I consisting of four thiazolothiazepines and test set II comprised of seven compounds belonging to an entirely different structural class of coumarins. Maximum Common Substructure (MCS) based method was used to align the molecules and this was compared with other known methods of alignment. Two methods of 3D QSAR: comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) were analyzed in terms of their predictive abilities. CoMSIA produced significantly better results for all correlations. The results indicate a strong correlation between the inhibitory activity of these compounds and the steric and electrostatic fields around them. CoMSIA models with considerable internal as well as external predictive ability were obtained. A poor correlation obtained with hydrophobic field indicates that the binding of thiazolothiazepines to HIV-1 integrase is mainly enthalpic in nature. Further the most active compound of the series was docked into the active site using the crystal structure of integrase. The binding site was formed by the amino acid residues 64-67, 116, 148, 151-152, 155-156, and 159. The comparison of coefficient contour maps with the steric and electrostatic properties of the receptor shows high level of compatibility.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12363217     DOI: 10.1023/a:1020137802155

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  31 in total

1.  The Cationminus signpi Interaction.

Authors:  Jennifer C. Ma; Dennis A. Dougherty
Journal:  Chem Rev       Date:  1997-08-05       Impact factor: 60.622

Review 2.  Genetics of retroviral integration.

Authors:  S P Goff
Journal:  Annu Rev Genet       Date:  1992       Impact factor: 16.830

Review 3.  HIV chemotherapy.

Authors:  D D Richman
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

4.  Integration is essential for efficient gene expression of human immunodeficiency virus type 1.

Authors:  H Sakai; M Kawamura; J Sakuragi; S Sakuragi; R Shibata; A Ishimoto; N Ono; S Ueda; A Adachi
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

5.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

6.  Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations.

Authors:  V M Gokhale; V M Kulkarni
Journal:  J Comput Aided Mol Des       Date:  2000-07       Impact factor: 3.686

7.  Coumarin-based inhibitors of HIV integrase.

Authors:  H Zhao; N Neamati; H Hong; A Mazumder; S Wang; S Sunder; G W Milne; Y Pommier; T R Burke
Journal:  J Med Chem       Date:  1997-01-17       Impact factor: 7.446

8.  Diarylsulfones, a novel class of human immunodeficiency virus type 1 integrase inhibitors.

Authors:  N Neamati; A Mazumder; H Zhao; S Sunder; T R Burke; R J Schultz; Y Pommier
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

9.  Thiazolothiazepine inhibitors of HIV-1 integrase.

Authors:  N Neamati; J A Turpin; H E Winslow; J L Christensen; K Williamson; A Orr; W G Rice; Y Pommier; A Garofalo; A Brizzi; G Campiani; I Fiorini; V Nacci
Journal:  J Med Chem       Date:  1999-08-26       Impact factor: 7.446

10.  Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.

Authors:  N Neamati; H Hong; J M Owen; S Sunder; H E Winslow; J L Christensen; H Zhao; T R Burke; G W Milne; Y Pommier
Journal:  J Med Chem       Date:  1998-08-13       Impact factor: 7.446

View more
  2 in total

Review 1.  Computer tools in the discovery of HIV-1 integrase inhibitors.

Authors:  Chenzhong Liao; Marc C Nicklaus
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

2.  Exploring the binding of HIV-1 integrase inhibitors by comparative residue interaction analysis (CoRIA).

Authors:  Devendra K Dhaked; Jitender Verma; Anil Saran; Evans C Coutinho
Journal:  J Mol Model       Date:  2008-12-02       Impact factor: 1.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.